APO RESEARCH · REPORT
10-Deacetylbaccatine III
A taxane intermediate supplied as 10-deacetylbaccatin III for separately specified synthesis or research uses.
Product & engineering
Understand the product.
Chemical identity, assay basis, impurities, solvent or carrier and the supplied form determine the material boundary. The substance name and an illustrative container do not establish grade, suitability, handling conditions or a finished-product performance claim.
What turns activity into demand
The selected edition segments 10-Deacetylbaccatine III by ≥95%; ≥98.0%; Others. Its application or channel categories include Production of Docetaxel; Production of Paclitaxel; Others.
The commercial boundary
Read those groups within the selected report’s geography, years and measure. Component, material and finished-system activity should not be combined unless that edition explicitly defines the same commercial scope.
Which composition and supplied-form specification defines the chemical product?
Chemical identity, assay basis, impurities, solvent or carrier and the supplied form determine the material boundary. The substance name and an illustrative container do not establish grade, suitability, handling conditions or a finished-product performance claim. The selected edition’s categories describe its research segmentation; a supplier specification and application-level acceptance test define the particular purchased product.
Technical reading
Selected research
Industry Research
10-Deacetylbaccatine III Industry Research Report 2026
Market perspective
The global 10-Deacetylbaccatine III market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for 10-Deacetylbaccatine III is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for 10-Deacetylbaccatine III is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for 10-Deacetylbaccatine III is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of 10-Deacetylbaccatine III include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global 10-Deacetylbaccatine III market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to 10-Deacetylbaccatine III.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
10-Deacetylbaccatine III Market by Company
Indena
South Pharmaceutical
Sai Phytoceuticals
Sarv Biolabs Pvt
Aphios
Taxus Pharma
Yunnan Hande
Kavya Pharma
Jinhe
Phyton Biotech
Deccan Nutraceuticals
Alchem International
10-Deacetylbaccatine III Segment by Type
≥95%
≥98.0%
Others
10-Deacetylbaccatine III Segment by Application
Production of Docetaxel
Production of Paclitaxel
Others
10-Deacetylbaccatine III Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 10-Deacetylbaccatine III market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 10-Deacetylbaccatine III and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 10-Deacetylbaccatine III.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of 10-Deacetylbaccatine III manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of 10-Deacetylbaccatine III by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of 10-Deacetylbaccatine III in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ≥95%
- ≥98.0%
- Others
Applications
- Production of Docetaxel
- Production of Paclitaxel
- Others
Companies covered
- Indena
- South Pharmaceutical
- Sai Phytoceuticals
- Sarv Biolabs Pvt
- Aphios
- Taxus Pharma
- Yunnan Hande
- Kavya Pharma
- Jinhe
- Phyton Biotech
- Deccan Nutraceuticals
- Alchem International
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 10-Deacetylbaccatine III by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 ≥95%
- 2.2.3 ≥98.0%
- 2.2.4 Others
- 2.3 10-Deacetylbaccatine III by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Production of Docetaxel
- 2.3.3 Production of Paclitaxel
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global 10-Deacetylbaccatine III Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global 10-Deacetylbaccatine III Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global 10-Deacetylbaccatine III Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global 10-Deacetylbaccatine III Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global 10-Deacetylbaccatine III Production by Manufacturers (2021-2026)
- 3.2 Global 10-Deacetylbaccatine III Production Value by Manufacturers (2021-2026)
- 3.3 Global 10-Deacetylbaccatine III Average Price by Manufacturers (2021-2026)
- 3.4 Global 10-Deacetylbaccatine III Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 10-Deacetylbaccatine III Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global 10-Deacetylbaccatine III Manufacturers, Product Type & Application
- 3.7 Global 10-Deacetylbaccatine III Manufacturers Established Date
- 3.8 Global 10-Deacetylbaccatine III Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Indena
- 4.1.1 Indena 10-Deacetylbaccatine III Company Information
- 4.1.2 Indena 10-Deacetylbaccatine III Business Overview
- 4.1.3 Indena 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Indena Product Portfolio
- 4.1.5 Indena Recent Developments
- 4.2 South Pharmaceutical
- 4.2.1 South Pharmaceutical 10-Deacetylbaccatine III Company Information
- 4.2.2 South Pharmaceutical 10-Deacetylbaccatine III Business Overview
- 4.2.3 South Pharmaceutical 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 South Pharmaceutical Product Portfolio
- 4.2.5 South Pharmaceutical Recent Developments
- 4.3 Sai Phytoceuticals
- 4.3.1 Sai Phytoceuticals 10-Deacetylbaccatine III Company Information
- 4.3.2 Sai Phytoceuticals 10-Deacetylbaccatine III Business Overview
- 4.3.3 Sai Phytoceuticals 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Sai Phytoceuticals Product Portfolio
- 4.3.5 Sai Phytoceuticals Recent Developments
- 4.4 Sarv Biolabs Pvt
- 4.4.1 Sarv Biolabs Pvt 10-Deacetylbaccatine III Company Information
- 4.4.2 Sarv Biolabs Pvt 10-Deacetylbaccatine III Business Overview
- 4.4.3 Sarv Biolabs Pvt 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Sarv Biolabs Pvt Product Portfolio
- 4.4.5 Sarv Biolabs Pvt Recent Developments
- 4.5 Aphios
- 4.5.1 Aphios 10-Deacetylbaccatine III Company Information
- 4.5.2 Aphios 10-Deacetylbaccatine III Business Overview
- 4.5.3 Aphios 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Aphios Product Portfolio
- 4.5.5 Aphios Recent Developments
- 4.6 Taxus Pharma
- 4.6.1 Taxus Pharma 10-Deacetylbaccatine III Company Information
- 4.6.2 Taxus Pharma 10-Deacetylbaccatine III Business Overview
- 4.6.3 Taxus Pharma 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Taxus Pharma Product Portfolio
- 4.6.5 Taxus Pharma Recent Developments
- 4.7 Yunnan Hande
- 4.7.1 Yunnan Hande 10-Deacetylbaccatine III Company Information
- 4.7.2 Yunnan Hande 10-Deacetylbaccatine III Business Overview
- 4.7.3 Yunnan Hande 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Yunnan Hande Product Portfolio
- 4.7.5 Yunnan Hande Recent Developments
- 4.8 Kavya Pharma
- 4.8.1 Kavya Pharma 10-Deacetylbaccatine III Company Information
- 4.8.2 Kavya Pharma 10-Deacetylbaccatine III Business Overview
- 4.8.3 Kavya Pharma 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Kavya Pharma Product Portfolio
- 4.8.5 Kavya Pharma Recent Developments
- 4.9 Jinhe
- 4.9.1 Jinhe 10-Deacetylbaccatine III Company Information
- 4.9.2 Jinhe 10-Deacetylbaccatine III Business Overview
- 4.9.3 Jinhe 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Jinhe Product Portfolio
- 4.9.5 Jinhe Recent Developments
- 4.10 Phyton Biotech
- 4.10.1 Phyton Biotech 10-Deacetylbaccatine III Company Information
- 4.10.2 Phyton Biotech 10-Deacetylbaccatine III Business Overview
- 4.10.3 Phyton Biotech 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Phyton Biotech Product Portfolio
- 4.10.5 Phyton Biotech Recent Developments
- 4.11 Deccan Nutraceuticals
- 4.11.1 Deccan Nutraceuticals 10-Deacetylbaccatine III Company Information
- 4.11.2 Deccan Nutraceuticals 10-Deacetylbaccatine III Business Overview
- 4.11.3 Deccan Nutraceuticals 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Deccan Nutraceuticals Product Portfolio
- 4.11.5 Deccan Nutraceuticals Recent Developments
- 4.12 Alchem International
- 4.12.1 Alchem International 10-Deacetylbaccatine III Company Information
- 4.12.2 Alchem International 10-Deacetylbaccatine III Business Overview
- 4.12.3 Alchem International 10-Deacetylbaccatine III Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Alchem International Product Portfolio
- 4.12.5 Alchem International Recent Developments
5 Global 10-Deacetylbaccatine III Production by Region
- 5.1 Global 10-Deacetylbaccatine III Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global 10-Deacetylbaccatine III Production by Region: 2021-2032
- 5.2.1 Global 10-Deacetylbaccatine III Production by Region: 2021-2026
- 5.2.2 Global 10-Deacetylbaccatine III Production Forecast by Region (2027-2032)
- 5.3 Global 10-Deacetylbaccatine III Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global 10-Deacetylbaccatine III Production Value by Region: 2021-2032
- 5.4.1 Global 10-Deacetylbaccatine III Production Value by Region: 2021-2026
- 5.4.2 Global 10-Deacetylbaccatine III Production Value Forecast by Region (2027-2032)
- 5.5 Global 10-Deacetylbaccatine III Market Price Analysis by Region (2021-2026)
- 5.6 Global 10-Deacetylbaccatine III Production and Value, YOY Growth
- 5.6.1 North America 10-Deacetylbaccatine III Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe 10-Deacetylbaccatine III Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China 10-Deacetylbaccatine III Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan 10-Deacetylbaccatine III Production Value Estimates and Forecasts (2021-2032)
6 Global 10-Deacetylbaccatine III Consumption by Region
- 6.1 Global 10-Deacetylbaccatine III Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global 10-Deacetylbaccatine III Consumption by Region (2021-2032)
- 6.2.1 Global 10-Deacetylbaccatine III Consumption by Region: 2021-2026
- 6.2.2 Global 10-Deacetylbaccatine III Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa 10-Deacetylbaccatine III Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa 10-Deacetylbaccatine III Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global 10-Deacetylbaccatine III Production by Type (2021-2032)
- 7.1.1 Global 10-Deacetylbaccatine III Production by Type (2021-2032) & (t)
- 7.1.2 Global 10-Deacetylbaccatine III Production Market Share by Type (2021-2032)
- 7.2 Global 10-Deacetylbaccatine III Production Value by Type (2021-2032)
- 7.2.1 Global 10-Deacetylbaccatine III Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global 10-Deacetylbaccatine III Production Value Market Share by Type (2021-2032)
- 7.3 Global 10-Deacetylbaccatine III Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global 10-Deacetylbaccatine III Production by Application (2021-2032)
- 8.1.1 Global 10-Deacetylbaccatine III Production by Application (2021-2032) & (t)
- 8.1.2 Global 10-Deacetylbaccatine III Production Market Share by Application (2021-2032)
- 8.2 Global 10-Deacetylbaccatine III Production Value by Application (2021-2032)
- 8.2.1 Global 10-Deacetylbaccatine III Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global 10-Deacetylbaccatine III Production Value Market Share by Application (2021-2032)
- 8.3 Global 10-Deacetylbaccatine III Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 10-Deacetylbaccatine III Value Chain Analysis
- 9.1.1 10-Deacetylbaccatine III Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 10-Deacetylbaccatine III Production Mode & Process
- 9.2 10-Deacetylbaccatine III Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 10-Deacetylbaccatine III Distributors
- 9.2.3 10-Deacetylbaccatine III Customers
10 Global 10-Deacetylbaccatine III Analyzing Market Dynamics
- 10.1 10-Deacetylbaccatine III Industry Trends
- 10.2 10-Deacetylbaccatine III Industry Drivers
- 10.3 10-Deacetylbaccatine III Industry Opportunities and Challenges
- 10.4 10-Deacetylbaccatine III Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst